Bonterra Resources set to raise up to $30 million Bonterra Resources Inc (CVE:BTR) (OTCMKTS:BONXF) said Thursday it will raise up to C$30 million in a private placement. 

According to the company, Sprott Capital Partners LP will act as lead agent. 

Bonterra has been advancing its gold projects in Quebec, which include the Gladiator, Barry and Moroy deposits. It also has 100% ownership of the Urban-Barry Mill, the only permitted gold mill in the region.

READ: Bonterra Resources unveils high grade drill results from Moroy zone

The company said the placement will consist of a mix of flow-through funds and non-flow-through funds.

The offering will consist of the sale of 1.87 million flow-through shares at C$2.67 per share. The gross proceeds from the issuance will be used for Canadian exploration expenses and will qualify as flow-through mining expenditures, as defined by Canada’s Income Act. A flow-through vehicle passes income to investors to avoid double taxation.

The non-flow-through placement will consist of the sale of 12.8 non-flow-through shares at a price of C$1.95 per share. Funds raised will be used for on-going exploration and development work on Bonterra's projects and for general corporate purposes.

The company also said it has granted an option to increase the size of the offering by up to 20%, which can be exercised at any time up to three days prior to the close, which is expected on or about March 15, 2019. 

All securities issued under the placement will be subject to a four-month hold period from the date of issue in compliance with applicable securities laws. The placement is subject to final acceptance of the TSX Venture Exchange.

Shares of Bonterra were at C$1.94 on Thursday. 

Contact Katie Lewis at

Thu, 21 Feb 2019 17:52:00 -0500
Mandalay Resources releases updated mineral resources and reserves estimate for Björkdal mine Mandalay Resources Corp (TSE:MND) (OTCMKTS:MNDJF) released encouraging news Thursday after it updated its mineral resources and reserves estimate for its Björkdal gold mine in northern Sweden.

According to the company, it approximately replaced depletion for production at the Björkdal mine in 2018 while measured and indicated mineral resources for contained gold increased slightly, as of December 31, 2018.

READ: Mandalay Resources closes C$43M offering

“We are pleased to have replaced depletion at Björkdal and maintained the operation’s 10-year mine life," said president and CEO Dominic Duffy in a statement. "In 2018, the focus of Mandalay’s exploration strategy at Björkdal shifted from adding ounces and extending mine life to discovering higher-grade ore sources that would improve mine economics. This shift in exploration focus yielded very exciting results, as late last year the company announced the discovery of the Aurora zone which has shown to be a significantly wider structure containing higher average grades than current production, with extensions up and down dip which are currently unconstrained."

Aurora discovery is encouraging

According to the company, initial mineral resources and reserves for the Aurora structure were "very encouraging."

It said as of a drilling cut-off date of September 30, 2018, the amount added from the Aurora discovery was 765,000 tonnes at 3.16 grams/tonne (g/t) gold for approximately 78,000 ounces of gold in the indicated resource category and 206,000 tonnes at 3.37 g/t gold for 22,000 ounces in the inferred resource category.

The company added that it also added mineral reserves from Aurora of 920,000 tonnes at 2.34 grams/ton gold for 69,000 gold ounces.

"We expect that Aurora will contribute additional mineral reserves and resources to Björkdal in 2019 based on existing drilling data that has not yet been incorporated into the estimate," said Duffy. "Further drilling has occurred on the Aurora structure since the cut-off date and is scheduled to continue over the course of 2019, as we focus on extensional drilling up and down dip as well as to the east. We also plan to drill from the surface to test up dip extension to the Aurora structure, as well as to test prospective zones surrounding Aurora, where no exploration has occurred to date.”

Lake Zone also promising

The company said it has also identified a smaller, but high-grade Lake Zone inferred resource of 57,000 tonnes at 7.63 g/t gold for approximately 14,000 gold ounces as of the drilling cut-off date. 

"Exploration during 2019 will also focus on identifying other high-grade skarn mineralization pockets," added Duffy. 

Shares of Mandalay Resources were at C$0.10 on Thursday.

Contact Katie Lewis at

Thu, 21 Feb 2019 16:43:00 -0500
Duos Technologies deploys new dcVue security software Duos Technologies Inc (OTCQB:DUOT) CFO Adrian Goldfarb and SVP of IT Infrastructure Services Joe Coschera tell Proactive Investors the Florida-based company has successfully deployed its new dcVue software as a commercial application for the first time.

Coschera says the dcVue system is designed to provide an accurate snapshot of all IT assets within a data center. Goldfarb adds that dcVue is part of a suite of products on a growth path for the company, which will contribute to the financial success of Duos.

Thu, 21 Feb 2019 16:32:00 -0500
Buds & Duds: Cannabis stocks stay green as Emerald Health Therapeutics and MYM Nutraceuticals shine Buds of the day include Emerald Health Therapeutics Inc (OTCMKTS:EMHTF), MYM Nutraceuticals Inc (CSE:MYM). Dud of the day is Canopy Growth (NYSE:CGC). 

Thu, 21 Feb 2019 16:31:00 -0500
CytoDyn files for Orphan Drug designation to treat triple-negative breast cancer CytoDyn Inc (OTCQB:CYDY) CEO Dr. Nader Pourhassan and Chief Medical Officer Dr. Richard Pestell tell Proactive Investors the biotech was able to reduce the incidence of human breast cancer metastasis in a mouse model for cancer with flagship drug leronlimab by more than 98%.

The biotech has filed for Orphan Drug designation to treat triple-negative breast cancer. It also announced plans earlier this week to expand pre-clinical animal studies into eight cancer indications.

Thu, 21 Feb 2019 15:05:00 -0500
ROBO Global says surgical robots will lower health care costs ROBO Global released a report earlier this week where it highlighted that surgical robots and automation will help in countering rising global health care costs.

ROBO Global created the ROBO Global Robotics & Automation Index, the world’s first benchmark index to track companies that focus on robotics, automation and artificial intelligence.

“Surgical robots can now perform complex surgeries with sub-millimeter accuracy, enabling surgeons to achieve far better patient outcomes,” according to ROBO's investor guide to health care robotics.

“Artificial intelligence is being used to view and expertly analyze medical images containing millions of cancer cells — within minutes and at a level of accuracy not possible by humans. Automation is creating enormous efficiencies across administrative and clinical research to improve and accelerate workflows.”

READ: ROBO Global says 3D printing poised for a high-growth, ‘profitable future’

According to Orian Research, the health care robotics market is expected to expand to $13.9 billion by 2023, at a compound annual growth rate of 28% over the next six years.

“Artificial intelligence is already driving revolutionary change in the medical field. But this does not mean that doctors will be replaced by medical robots. Far from it,” ROBO Global CIO and President William Studebaker earlier told Proactive Investors. “Instead, AI will continue to bolster the capabilities of physicians and the medical devices and machines they use every day to deliver better patient outcomes.”

Health care accounts for 10% of the ROBO Index, with a focus on robotics guidance and surgery, laboratory automation, genomics, and AI healthcare applications. The sector returned more than 21% in the first 11 months of 2018.

At least nine health care companies with headquarters in four different countries are components of the ROBO benchmark index.

“Today, Intuitive Surgical (NASDAQ:ISRG) is trading around $500/share but we believe they are still in the early innings of a sustainable growth story,” according to the report.

“Intuitive Surgical has a virtual monopoly on surgical robotics with its da Vinci Xi system which uses 3D vision and intuitive motion to improve minimally invasive procedures and help surgeons deliver better outcomes for cardiac, thoracic, urology, gynecologic, colorectal pediatric and general surgeries,” the report continued.

In terms of the ROBO Global Robotics & Automation Index, Intuitive Surgical is considered a “pure-play” or bellwether company in the industry. In the ROBO world pure-play stocks — companies such as Intuitive Surgical and iRobot Corp (NASDAQ:IRBT)  — have an approximate 2% weighting in the 87-strong ROBO index. The hybrids are individually at about 1%.

M&A on the rise

ROBO Global says that there will be continued investments in robotics and artificial intelligence, as well as a new wave of M&A by traditional health care companies in the medical device and instrument arena as they seek new avenues for growth.

In 2018, spine robotics surgery pioneer Mazor Robotics — which has been the best performing constituent of the ROBO Index in the past three years — agreed to be acquired by Medtronic PLC’s (NYSE:MDT) for over $1.6 billion.

Index component Globus Medical Inc (NYSE:GMED) is also making headway in this area, driving significant technological advancements across a complete suite of spinal products.

The ROBO index is used as a performance benchmark for funds and market growth. Since it’s the first major index in the robotics, automation and AI space, the ROBO index has several low-cost ETFs tied to it at the hip. 

ROBO Global provides its expertise to the ROBO Global Robotics and Automation Index ETF (NYSEARCA:ROBO) which was trading flat at $38.59 on Thursday.

Contact Uttara Choudhury at

Follow her on Twitter@UttaraProactive 

Thu, 21 Feb 2019 14:44:00 -0500
Tests show Pressure BioSciences' Ultra Shear Technology effective for processing CBD oil Pressure BioSciences Inc (OTCQB:PBIO) said Thursday that lab tests have confirmed that cannabidiol (CBD) oil prepared using its novel Ultra Shear Technology (UST) met challenging nanoemulsion specifications with minimal CBD loss during processing.

Analytical testing on hemp-derived CBD oil processed using Ultra Shear Technology met the “challenging criteria” for creating “highly-effective nanoemulsions” of CBD oil in water, without loss or modification of CBD throughout the entire process, said the company.

The South Easton, Massachusetts, company utilizes high pressure to create intense, momentary liquid shearing forces at controlled temperatures that result in affordable and scalable homogenization of liquids, creams and gels. The technology creates nano-scale emulsion mixtures of otherwise immiscible fluids -- like oils in water -- that results in stable homogenized products called nanoemulsions.

READ: Pressure BioSciences' Ultra Shear Technology system may solve the cannabinoid delivery issue

For many oil-based nutritional and medical products, nanoemulsions can offer superior water solubility and increased bio-availability for improved absorption via oral or topical administration. As a result, the technology has wide potential uses in the pharmaceutical, industrial ink, retail, cosmetics and now burgeoning CBD oil market. 

"We asked an independent, university-affiliated lab to determine the size of oil droplets achieved in Ultra Shear Technology-processed CBD oil, using a universally-accepted sizing method called DLS,” said Dr Vera Gross, director of applications development at Pressure BioSciences. “Their analytical results revealed that the UST-processed oil drops were reduced to approximately 65 nm in size, well into the 20-200 nm range targeted for truly effective nanoemulsion delivery and absorption of nutrients and therapeutics such as CBD."

The company also demonstrated that CBD from hemp-derived CBD oil was not lost or modified during processing by enlisting the help of scientists at NutraFuels Inc (OTCMKTS:NTFU) who work in an FDA-inspected lab.

"Using a powerful laboratory method called HPLC to measure the concentrations of CBD and potential impurities, we determined that no appreciable amount of CBD was lost during the UST process,” said Cooper Dodd, R&D scientist at NutraFuels. “These results compare well to our standard processing method of ultrasonication, which can carry a risk of measurable loss of CBD, and sometimes creates the appearance of impurities if not performed properly… As a nutraceutical manufacturer with products already on the market, we see these results as a robust leap towards better optimization of our CBD-enhanced products."

Dr Keith Warriner, professor of food science at the University of Guelph, in Toronto and an expert in the cannabis industry, said the data on UST-generated nanoemulsions of CBD oil was “very impressive.”

“Creating nanoemulsions of CBD oil with full preservation of CBD throughout the process, while not generating impurities, remains a significant challenge in the industry. The data indicates that UST can achieve that goal, thereby offering great promise," said Warriner.

Not only did the UST process appear capable of achieving “stability of emulsions,” he added, but the controlled heating that also occurs may offer a valid alternative to thermal and non-thermal pasteurization methods to reduce the risk of harmful microbes in products such as edibles and topicals.

“I believe that CBD-infused topicals and similar products will prove more popular with users than edibles. However, to be successful, it is imperative that topicals be highly stable, safe, bioavailable, and readily absorbent nanoemulsions. After consideration of the data released today, the UST process appears to be a leading candidate to fill that important need," said Warriner.

Contact Uttara Choudhury at

Follow her on Twitter@UttaraProactive 

Thu, 21 Feb 2019 12:36:00 -0500
AusCann Group secures supplier of cannabis resin for upcoming manufacturing AusCann Group Holdings Ltd (ASX:AC8) has entered into a supply agreement to purchase cannabis resin from MediPharm Labs Corporation (TSXV:LABS) (OTCQB:MLCPF).

The high-grade cannabis resin will primarily be used in the manufacture of AusCann’s first product line of hard-shell cannabinoid capsules.

MediPharm is Canada’s largest and most experienced supplier of purified, pharmaceutical grade cannabis extracts.

Its state-of-the-art facility is one of the most innovative and technically advanced in the cannabis industry.

First supply under the deal is set to commence in the coming months.

READ: AusCann Group on track to produce cannabinoid medicines this year

AusCann’s interim CEO Dr Paul MacLeman said: “Reliable supply of pharma-grade cannabinoid extracts through MediPharm’s proprietary methodologies will support AusCann’s ability to develop and deliver quality cannabinoid medicines.

"Critical for the company are repeatability in manufacturing, reliable dosing, and purity assurance.

“These product foundations will allow delivery of effective, trusted and safe medicines for the treatment of chronic pain.”

Plans for multiple suppliers to lower risk

AusCann is working towards securing a small number of validated, safe and reliable sources of cannabis resins as ongoing inputs into its pharmaceutical product development, clinical trials and product sales activities.

This multi-supplier strategy mitigates and reduces supply risks and enables AusCann to work efficiently with specialists in different types of extracts across a number of jurisdictions.

It also supports AusCann’s focus upon novel dose form development to optimise patient outcomes and create valuable pharmaceutical products for the Australian and export markets.

Thu, 21 Feb 2019 12:32:00 -0500
High Hampton aims to be California brands and distribution leader
  • Completed acquisition of Mojave Jane, a California-licensed manufacturer of premium cannabis extracts and concentrates

  • Wholly owned subsidiary 420 Realty received six California state cannabis licenses

  • Company is predicting revenue will arrive in early 2019

  • Its distribution business, Bravo, churning towards operations, is expecting to be licensed in Q2 2019

  • What High Hampton Holdings does

    High Hampton Holdings Corp (CSE:HC) (OTCMKTS:HHPHF) is a Canadian-based cannabis sector investment company focused on California and aims to become a vertical integrator in the state’s legal cannabis space serving recreational and medicinal markets.

    The Vancouver-based company has been focused on identifying, acquiring and developing assets in the California market to address all aspects of the cannabis business: from cultivation through production. It will own and operate the processes that allow the company to manufacture, infuse and package branded recreational and wellness products.

    The company says the key focus of the business is the ability to create brands and control the distribution of those brands in California. As a result, it’s building out businesses in all of those spaces.

    How is it doing?

    The company is predicting that revenue will arrive in early 2019.

    Two of High Hampton's current brands, Cali-Gold and Mojave Jane, are well recognized for quality, and have cleared California’s licensing hurdles and begun operations. Both teams are in place it is expected both businesses will produce and ship products in early 2019.

    High Hampton’s cornerstone distribution business, Bravo, continues to make progress towards operations as well, with a 15,000 sq/ft facility under lease in West Sacramento.

    The appropriate applications have been submitted, and the facility and the business expect to be licensed in early Q2 and operational in late Q2 of 2019.

    In January, the company said its wholly-owned subsidiary 420 Realty LLC received six California state cannabis licenses to operate at its facility located in the City of Cudahy. The granting of six temporary licenses for nursery work, cultivation processing, cultivation, manufacturing, retail and distribution will allow 420 Realty to kick off the development of its facility in Cudahy.

    In other news, High Hampton’s 11-acre CoachellaGro property in Coachella, CA  received its conditional use permit, allowing design to begin. The company says power design and development of CoachellaGro are being done in a modular fashion, which will allow the company to respond to the changing market dynamics for flower and bio-mass in California.

    From a financing perspective, liquidity remains strong with over $9 million in cash as of November 30th, 2018.

    Recent months have seen High Hampton focused on making its 2018 acquisitions operational and 2019 looks bright when it comes to generating revenues.

    What the boss says

    “The focus of the business is to develop the cannabis space in California, principally,” says CEO Gary Latham. “High Hampton has been concentrating on identifying, acquiring and developing assets in the California market, both southern California and central and northern California to address all aspects of the cannabis business -- from cultivation all the way through production of distillates and oils through the production of edible products.

    “Most importantly and what we see as key to the business is being able to create brands and control the distribution of those brands,” says Latham.



    Contact Katie Lewis at

    Follow her on Twitter @kelewis

    Thu, 21 Feb 2019 12:16:00 -0500
    Cobalt has had a stormy year, does the blue metal have blue skies ahead? Proactive Investor's Heavy Metals takes a deep dive in the world of cobalt. It has seen some tough times in recent months, but with more and more electric vehicles on the roads, does that bode well for the metal in the future?

    Thu, 21 Feb 2019 11:47:00 -0500
    Pacton Gold makes TSX Venture's top-performers list Pacton Gold Inc (CVE:PAC) (OTCMKTS:PACXF) is looking golden after being named one of TSX Venture Exchange’s top-performing companies in 2019.

    The Vancouver-based junior exploration company made the Venture Exchange's 2019 TSX Venture 50 list. 

    The list of 50 companies comprises 10 from each of five sectors, selected based on market cap growth, share price appreciation and trading volume.

    READ: Pacton Gold further strengthens footprint in famous Red Lake district

    "During the past year we have aggressively established ourselves in two of the most promising gold exploration districts in the world, namely Western Australia and Red Lake, Ontario," said executive chairman Dale Ginn. 

    "This year's focus will be on actively exploring our projects for high-grade gold and we anticipate that Pacton Gold will continue to be one of the most active gold explorers on the Venture Exchange during 2019 and beyond."

    Shares of Pacton Gold were at C$0.26 on Thursday.

    Contact Katie Lewis at

    Follow her on Twitter @kelewis

    Thu, 21 Feb 2019 11:31:00 -0500
    CROP Infrastructure and Hempire make big inroads into California with Antler Retail CROP Infrastructure Corp (OTCMKTS:CRXPF) (CNSX:CROP) announced Thursday that it has signed an agreement with Antler Retail Inc by which Hempire and CROP will provide Antler with finished packaged goods under the Antler brand.

    Antler has received a permit for a cannabis retail location with state-wide delivery rights in California. Antler’s retail location will be in Desert Hot Springs, but it plans to take advantage of the state-wide nature of its delivery rights. The license gives Antler the freedom to target a much larger market place without the overhead costs of brick-and-mortar operations.

    READ: CROP Infrastructure receives 2019 production, extraction licenses for Nevada hemp operations

    CROP said it was converting the payment for the initial order into shares in Antler Retail at C$0.20 per unit by issuing 1.5 million units. Each unit will consist of one share and a warrant priced at C$0.75 exercisable for a period of 12 months.

    "We believe it is a prudent move for our company to convert our finished products into shares of Antler retail,” said CROP CEO Michael Yorke. “We see this as an opportunity to not only assist Antler in entering additional states, but also as a big step forward in further establishing CROP's retail presence in a key market, while making what we believe will be a very sound investment."

    As Antler makes inroads into other US states, the supply agreement will be amended to bring the Antler home brand to each new state Antler enters, said the company.

    CROP’s portfolio of cannabis projects include cultivation properties in California and Washington state, a 1,000-acre Nevada cannabis farm and extraction work in Nevada.

    CROP subsidiary Elite Ventures has also completed a 1,600 square foot genetics, tissue-culturing and micropropagation lab at its Nevada tetrahydrocannabinol farm.

    Contact Uttara Choudhury at

    Follow her on Twitter@UttaraProactive 


    Thu, 21 Feb 2019 10:49:00 -0500
    Universal mCloud named one of TSX Venture's top performers in 2019 Universal mCloud Corp (TSX-V:MCLD) (OTCQB:MCLDF) has been named one of TSX Venture Exchange’s top-performing companies in 2019.

    The specialist in artificial intelligence and the Internet of Things is among the Venture Exchange’s top picks for the tech sector.

    Shares of the Vancouver-based company jumped 8.2% to C$0.33 in Toronto trading with the news.

    READ: Universal mCloud teams up with Chinese partner to deliver smart-building technology

    The list of 50 companies is comprised of 10 from each of five sectors, selected based on market cap growth, share price appreciation and trading volume.

    "Less than a year and a half ago, mCloud began trading on the TSX Venture Exchange," said Universal mCloud CEO Russ McMeekin in a statement. "In this short period of time, we have executed our strategy and meaningfully developed our business, growing our number of connected assets from six thousand to 28 thousand.”

    Contact Paul Curcio at

    Follow him on Twitter @GoCurcioGo

    Thu, 21 Feb 2019 10:45:00 -0500
    Redfund Capital expands deal with Wahupta Ventures to provide new financing Redfund Capital Corp (CSE:LOAN) (OTCMKTS:PNNRF) said Thursday that it has expanded its advisory deal with Wahupta Ventures Inc. to include new financing.

    Vancouver-based Redfund has agreed to invest up to $1 million in Wahupta to help build out its growing Canadian hemp operations.

    READ: Redfund Capital taps industry veteran Warren D Cudney as new strategic advisor

    Redfund Capital provides debt and equity funding in the mid-to-late stages of a target cannabis company’s development. Its focus is on companies specializing in medical cannabis as well as health care and hemp and CBD-related products.

    Wahupta, which is based in Canada, cultivates, processes and extracts hemp and cannibidiol (CBD) in collaboration with sovereign Indigenous communities throughout North America. The company is also partnered with Canadian hemp-food manufacturer Naturally Splendid Enterprises.

    “We believe strongly in the team and their vision at Wahupta, and are eager as well to work with their partner Naturally Splendid in developing client and proprietary hemp products,” said Redfund CEO Meris Kott. “We look forward to helping assist Wahupta to the next level of their strategic plan with additional capital.”

    Contact Paul Curcio at

    Follow him on Twitter @GoCurcioGo

    Thu, 21 Feb 2019 09:43:00 -0500
    eWellness looks to train physical therapists in its digital PT program eWellness Healthcare Corp (OTCQB:EWLL) announced Thursday that it has kicked off a weekly PHZIO system webinar training program for physical therapists who would like to become experts in treating patients via its digital course of physical therapy.

    The new program has been set up to recruit more physical therapists to take on cases coming from existing and future workman’s compensation contracts handled by eWellness.

    READ: eWellness Healthcare sparks digital revolution in physical therapy

    “Our focus is to highlight that a majority of all future physical therapy treatments can be accomplished with a smart phone,” said Darwin Fogt, eWellness’s CEO in a statement. “This new digital adoption will lower patient treatment costs, expand patient treatment access and improve patience compliance.”

    So far, over 200 physical therapists have been trained on eWellness’s PHZIO platform.

    Based in Culver City, California, eWellness is a physical therapy telehealth company that offers an online course of physical therapy treatments. It is looking to license its PHZIO platform to physical therapy clinics and have employers use the PHZIO platform as part of corporate wellness programs.

    According to eWellness, about 80% of all physical therapy assessments and treatments can be done on a patient’s smart phone while at home.

    Contact Ellen Kelleher at


    Thu, 21 Feb 2019 09:26:00 -0500
    Endeavour Mining taps Mark Morcombe as chief operating officer Endeavour Mining Corp (TSX:EDV) (OTMKTS:EDVMF) has hired a new chief operating officer, Mark Morcombe.

    The London-based gold producer said Thursday that Morcombe will take over from Jeremy Langford as of May 6. Langford is set to depart as COO of the mining company on February 28.

    Morcombe is a mining veteran with more than 25 years of experience leading cost and productivity initiatives. He has been COO of Centamin PLC since January 2018, with previous stops at Acacia Mining PLC and AngloGold Ashanti Ltd (NYSE:AU).

    READ: Endeavour Mining on budget and ahead of schedule with Ity CIL project commissioning

    “We are very pleased to welcome Mark to Endeavour as he has a strong operating track record, notably with Tier 1 African mines,” said Sébastien de Montessus, president and CEO of Endeavour Mining, in a statement.

    The CEO also thanked Langford, who is leaving to pursue other opportunities, for his role in designing and constructing most of the company’s operating assets and for putting together a core construction team.

    Contact Paul Curcio at

    Follow him on Twitter @GoCurcioGo

    Thu, 21 Feb 2019 08:59:00 -0500
    1933 Industries to showcase its CBD products at Oscars festivities 1933 Industries (CSE:TGIF) (OTCQX:TGIFF) is having its day on the red carpet as it will be giving out some of its hemp-derived CBD products at an Oscars-related event on Friday at the W Hotel in Beverly Hills.

    As part of the festivities, a team from 1933 Industries’ subsidiary Infused MFG will be giving out free CBD Relief Cream and other CBD elixirs at the WOW Creations Celebrity Gift lounge at the W.

    READ: 1933 Industries stokes Las Vegas capacity expansion in anticipation of medical and recreational cannabis product demand

    “We look forward to introducing our products to a celebrity audience during the week of the Academy Awards,” said Chris Rebentisch, USA chief operations officer.

    Canna Hemp CBD relief cream takes aim at inflammation, arthritis joint pain, backaches, muscle spasms, bruises, cramps and headaches.

    Operating via three subsidiaries, 1933 specializes in licensed medical and recreational cannabis cultivation and production as well as hemp-based and CBD-infused products and CBD extraction services.

    The company owns 91% of both the Alternative Medicine Association and Infused MFG and 100% of Spire Global Strategy, a cannabis advisory firm.

    1933 shares closed 3.6% higher to hit C$0.59 on Wednesday.

    Contact Ellen Kelleher at

    Thu, 21 Feb 2019 08:55:00 -0500
    Allot research finds closed loop automation adoption is key to delivering quality in high-speed 5G networks Allot Ltd (NASDAQ:ALLT) (TASE:ALLT), a security and smart network intelligence solutions company, released findings Thursday from its “Telco Smart Trends” report, identifying the need for communications service providers to embrace Closed Loop Automation (CLA) to ensure quality.

    In layman’s terms, closed-loop automation is akin to tasting a dish and adjusting the recipe until you reach perfection. By closing the loop, you ensure the system works as intended. This concept is also known as Intent Based Networking (IBN). In other words, closed-loop automation is a prerequisite to deploying intent-based network services.

    The report also highlights that the Internet of Things and security, fueled by the onset of 5G networks offering faster speeds and more reliable connections on smartphones and other devices, will be key drivers for CLA adoption. The report details findings from a survey conducted among 100 communications service providers worldwide to gauge the value they perceive CLA adds.

     Key findings of the report include:

    • Despite the benefits that CLA provides in 4G networks, three-quarters of respondents feel that CLA will be most important in either the transition period (50%) or once they have fully implemented 5G (25%).
    • Around two-thirds of respondents strongly agree that CLA is important to the growth of security and IoT services.
    • Independent Software Vendors are best positioned to deliver CLA with the added machine learning and artificial intelligence capabilities that cost-effectively ensure optimal performance, security and quality.
    • The main barriers to implementing CLA solutions for organizations are having the skills to use the technology to the full, understanding the technology, and cost.

    "Communications service providers are keenly aware of the high vulnerability associated with IoT devices and services," said Akshay Sharma at neXt Curve.

    "CLA will be a critical capability for effectively handling the mounting IoT threats, magnified by the scale of 5G."

    Allot said that communications service providers already realize that they need to embrace CLA and not doing so will prove costly in the long-term.

    “Our report points to the fact that the CLA inherent in 5G is not enough and independent software vendors have the opportunity to provide the additional CLA functionality, powered by AI and ML to meet the growing QoE expectations," said Ronen Priel, vice president, Product and Strategy at Allot.

    Allot NetworkSecure is the world’s largest deployed network-based security service for the mass market, with over 21 million paying security customers.

    Contact Uttara Choudhury at

    Follow her on Twitter@UttaraProactive 

    Thu, 21 Feb 2019 08:46:00 -0500
    American Rebel Holdings CEO sees consumers and businesses gravitating toward its specialty brand American Rebel Holdings Inc (OTCQB:AREB) CEO Andy Ross tells Proactive Investors the specialty apparel company saw a sales surge at the Nation’s Best Sports Show 2019 in Texas and the Great American Outdoor Show in Pennsylvania.

    Ross is off next to the Iowa Deer Classic in Des Moines, followed by The NRA Annual Convention in Indianapolis.

    Thu, 21 Feb 2019 08:24:00 -0500
    Lexaria Bioscience announces optimistic new trial results for its hemp oil capsule TurboCBD Lexaria Bioscience Corp (OTCQX:LXRP) (CSE:LXX) alerted investors on Thursday to a series of optimistic findings from a 2018 European study evaluating TurboCBD, its Dehydratech-powered cannabidiol (CBD) fortified hemp oil capsule.

    Results from the study reveal that a single 90mg dose of TurboCBD showed evidence of lower blood pressure; higher blood flow to the brain; faster delivery of CBD into the bloodstream and larger quantities of CBD within the blood when measured against a single 90mg dose of generic CBD.

    The study also suggested that Lexaria’s Dehydratech technology allows for better cannabinoid delivery upon ingestion.

    READ: Lexaria Bioscience inks deal with Altria Ventures to develop reduced-risk nicotine products; shares soar

    As part of the trial 90mg  dose of Lexaria’s TurboCBD was compared to the effects of a 90mg CBD dose without Lexaria’s Dehydratech technology (the positive control) as well as a placebo.

    And analysis when CBD was at peak blood levels, thanks to Lexaria’s TurboCBD using DehydraTECH, showed a significant reduction in mean arterial blood pressure (MAP) compared to both the placebo and the generic CBD. This result highlights the usefulness of Lexaria's technology to allow for CBD to reduce blood pressure.

    READ: Lexaria Bioscience: The cannabis company developing a potentially life-saving technology

    “The findings that Lexaria’s Dehydratech technology can enable superior cannabinoid delivery are unique in this healthy-human clinical trial,” said Dr Phlip Ainslie, principal investigator and co-director of the Centre for Heart, Lung and Vascular Health at UBC Okanagan Campus, Kelowna, Canada. “Establishing the impact of CBD delivery on the health of the circulatory systems, including the brain, could have major implications for the adjunct treatment of high blood pressure and some neurological diseases.”

    On the back of the study, Lexaria intends to conduct further clinical investigations within the next year using Dehydratech for cannabinoids with an expanded number of subjects over a more varied age range. Additional data and reports will be provided from future studies as they become available.

    Based in Kelowna, British Columbia, Lexaria has developed and licenses out its disruptive delivery technology which increases intestinal absorption rates and offers more rapid delivery to the bloodstream. Dehydratech is essentially a delivery system that allows drugs and vitamins to get into the bloodstream quicker.

    Lexaria shares slipped 2% to finish at C$1.94 on Wednesday.

    Contact Ellen Kelleher at 

    Thu, 21 Feb 2019 08:00:00 -0500
    Eve & Co prepares to expand cannabis production facilities in Ontario Eve & Co. (CVE:EVE) CEO Melinda Rombouts joined Steve Darling from Proactive Investors Vancouver on Skype to talk about their cannabis company located in Ontario. Their cultivation facility sits on a 32 acres property with annual production of 10,000 KG, but is expand to 50,000 this summer.

    Rombouts also told Proactive about their long term plans with company and which markets she sees at potential for sales growth. 

    Thu, 21 Feb 2019 07:59:00 -0500
    Pareteum Corp price target raised to $7.50 by analysts at Taglich Brothers Analysts at Taglich Brothers reiterated their Speculative Buy rating on Pareteum Corp (NASDAQ:TEUM) and raised their price target for the cloud software company to $7.50 per share from $5, based on increased revenue projection.

    Pareteum recently announced it acquired iPass in an all-stock transaction for up to $25.3 million in stock and assumption of debt.

    “We are reiterating our Speculative Buy rating on Pareteum Corporation and raising our twelve-month price target to $7.50 per share from $5.00 based on our increased 2019 revenue projection stemming from the acquisition of iPass,” Taglich Brothers analyst John Nobile wrote in a note to clients on Wednesday.

    READ: Cloud company Pareteum reaches new heights, scooping up more than $400M in contracts

    “The acquisition resulted in a significant increase to our 2019 revenue forecast due to the impact over the final 10 months of the year,” he added.  

    Pareteum stock closed 1.7% higher on Wednesday to $3.7.

    The analyst said that a day after the iPass acquisition was announced, the company announced that its 36-month backlog more than quadrupled to over $600 million from $147 million in December 31, 2017.

    “Pareteum’s 36-month contractual backlog and synergies (through cross selling, market expansion, and cost savings) created by the acquisition of iPass should support our revenue growth forecasts,” wrote Nobile. 

    “We project strong revenue growth should result in EBITDA of $24.6 million in 2019, up from a projected loss of $2.2 million in 2018,” he added.

    The analyst said that his favorable “revised forecast” reflected the acquisition of iPass.  

    “For 2019, we project revenue more than tripling to $113 million and net income of $17.1 million or $0.15 per share. We previously forecasted revenue of $82 million and net income of $18.9 million or $0.18 per share,” wrote Nobile.   

    The analyst said that the rating should be supported by worldwide spending on public cloud services and infrastructure, which is forecast to achieve a five-year compound annual growth rate of 21.9% with public cloud services spending totaling $277 billion by 2021.

    Contact Uttara Choudhury at

    Follow her on Twitter@UttaraProactive 

    Thu, 21 Feb 2019 07:52:00 -0500
    Inseego is a microcap play for the coming 5G revolution Up until about 15 years ago, most consumers believed a cable subscription was necessary to watch TV, surf the internet, and in some cases, talk on the phone. But thanks to increased internet speeds, reduced latency, and improved internet stability, consumers have options.

    And those options begin with cutting the cord. 

    It’s no longer necessary to pay Comcast, Cox, or Time Warner an obscene amount of money to watch TV or talk on the phone. An internet connection and a relatively inexpensive smart TV are all that are needed to enjoy the wonders of Netflix, YouTube TV, Sling, and Apple TV.

    Byrne: Charlotte’s Web spins a tale of growth in the hemp-based CBD space

    And thanks to the consistent downward spiral in cell phone plan pricing, most consumers no longer need landline telephone service.

    But wait, what about the internet?

    While canceling that expensive monthly cable TV subscription and ditching the landline telephone service is fantastic, we still need the internet. Netflix and Apple TV won’t work on their own; an internet connection is still required.

    If you’re like me, you’re probably counting the days until you’re no longer reliant on a cable wire running from a three-foot vertical box on the back corner of your property line, into your home office and throughout all the rooms of your home. Unfortunately, neither you nor I have a choice. Because satellite-provided internet is unreliable and the current wireless standard, 4G LTE, isn’t fast enough for most households to eliminate wired broadband (cable).

    But 5G mobile internet connectivity is coming, and it’s bringing with it significantly faster-than-cable internet speeds, with ultra-low latency and the ability to connect all your Internet of Things (IoT) devices.

    The bottom line is 5G is going to change the way you watch TV, surf the net, and live your life.

    Profiting from the rollout of 5G

    If you’re interested in investing in the 5G revolution, you have several options.

    A diversified large-cap approach would involve buying a basket of stocks like Apple Inc (NASDAQ:AAPL), Verizon (NYSE:VZ), AT&T (NYSE:T), Qualcomm (NASDAQ:QCOM), and Skyworks (NASDAQ:SWKS). While a large-cap basket approach is a fine strategy, you’re likely trading the potential for outsized gains for increased safety.

    A second option would be to forgo investment safety in favor of home-run investment potential and investigate a microcap company that has the potential to grow exponentially from its role as an early player in the rollout of 5G.

    And if it’s home-run potential you’re after, then Inseego Corp (NASDAQ:INSG) should be at the top of your 5G-related watchlist.

    Byrne: CannTrust Holdings is a steady grower in a rapidly maturing cannabis industry

    San Diego, California-based Inseego is a $365 million company dedicated to the design and development of products that enable high-performance mobile applications for large enterprise verticals, service providers, and small and medium-sized business around the globe.

    In simpler terms, Inseego provides software-as-a-service (SaaS), Internet of Things (IoT), and mobile solutions for both the enterprise and residential consumer worldwide.

    While you’re probably unfamiliar with Inseego, you may recognize the company’s previous name – Novatel Wireless and its MiFi wireless router.

    Novatel produced the MiFi mobile Wi-Fi hotspot wireless router for years, but as that business began to decline, the company agreed to sell the MiFi brand to TCL Industries Holdings of Hong Kong.

    However, between the time the original agreement was signed in 2016, and when the Committee on Foreign Investment in the United States (CFIUS) requested additional time to review the transaction in late May 2017, Novatel realized it made more sense to restructure the company, retain the MiFi Business and the associated technical know-how and hang on to its valuable intellectual property.

    Novatel, renamed Inseego in 2016, recognized the potential of the newly emerging 5G NR standard, and on June 8, 2017, replaced CEO and chair Sue Swenson with Dan Mondor as CEO, and HC2/Harbinger’s Philip Falcone as chairman.

    Under new leadership and with the emerging 5G technology as their guiding light, Inseego set out to restructure the company and identify millions of dollars in annualized cost savings, boost operating efficiencies, and exit its underperforming businesses. All these actions were taken to return the company to a positive free cash flow position and grow its EBITDA in as short a time as possible.

    Diversified business segments

    Inseego isn’t only focused on opportunities arising from the deployment and buildout of 5G. The company also has an IoT business called Skyus, which will likely benefit from 5G, and a SaaS business.

    Skyus isn’t an unusually large business segment, but Inseego believes it is on solid footing with its loyal customer following and plans to continue investing and growing their IoT and industrial IoT portfolio of products to take advantage of that industry’s 5G-related growth.

    Inseego’s SaaS business, which is led by senior vice president John Weldon, consists of subscription offerings to the company’s Ctrack telematics platforms for the tracking and performance analysis of fleet and aviation ground vehicles, other telematics applications, and Device Management Systems (DMS).

    Byrne: Why market volatility signals a return to normalcy for investors

    While it’s great to see Inseego nurturing its IoT and SaaS business segments, it’s the company’s potential to be a significant player in the first phase of the 5G rollout that attracted me to the name.

    You see, 5G is a very different animal from 4G.

    When 4G was rolled out, Inseego’s (then Novatel) MiFi products lost their appeal as mobile hot spots because one’s phone had similar functionality. But 5G is not starting as a mobile phone product. It’s beginning with fixed wireless at home. And as residential 5G users sign up for service, they’re going to need 5G-compatible routers and hotspots – and that’s where Inseego comes into play.

    With all the scrutiny surrounding Chinese companies like Huawei and ZTE, Inseego has the potential to emerge as a significant player in the early, residential buildout of 5G. And thanks to Inseego’s Verizon-branded 5G mobile hotspot device, the company already has its foot in the door!

    Improving financials

    Investors received their first evidence that Inseego’s restructuring and turnaround plan was working when the company released second-quarter 2018 financial results on August 7, 2018.

    In that report, Inseego disclosed that despite a double-digit decline in revenue, gross profit increased, the company’s operating loss narrowed substantially, and operating expenses were slashed.

    Wall Street, having written Inseego off for dead when its shares were trading under a buck just days after Mondor took over for Swenson as CEO in early June 2017, now had a reason to give the company a second look.

    Inseego’s shares soared from around $2 when its 2Q results were released in early August 2018, to more than $4 in a month. But investors weren’t in a hurry to cash in, as the stock was still trading near $4 when the company released third-quarter results on August 6, 2018.

    Here’s what Inseego’s CEO Dan Mondor said when his company, newly restructure and in full turnaround mode, released 3Q 2018 financial results on November 6, 2018:

    “Q3 was Inseego’s strongest quarter in years. We had record adjusted EBITDA and made tremendous progress in the newly evolving 5G market with key customer wins. Despite significant revenue headwinds during the quarter due to foreign exchange rates and supply chain constraints we delivered results that keep us on track to meet our target adjusted EBITDA run-rate exiting 2018. Inseego’s progress demonstrates our customers’ interest in our latest innovations and ability to deliver market-leading solutions.”

    Inseego went on to include the following IoT and Mobile 5G solutions highlights in their third-quarter release:

    • 3Q 2018 net revenue of $34.6 million, 9% quarter-over-quarter growth.
    • Announced R1000 wireless home gateway solution supporting Verizon 5G Home, the world’s first 5G broadband internet service.
    • Awarded 5G NR hotspot business with global Tier 1 service providers in North America and international regions.

    When Inseego reports fourth-quarter 2018 results on March 7, investors will be looking at the company’s consolidated revenue, adjusted EBITDA, and operating expenses. If operating expenses continue to contract and the company reports a revenue figure toward the top end of its $51 million to $57 million outlook it provided in November, I’d expect investors to respond by bidding shares higher.

    Charting a long-term breakout

    Inseego’s stock chart is an accurate depiction of the company’s business struggles over the past 10 years. But since bottoming out under a buck shortly after Mondor took over for Swenson, Inseego’s stock has strengthened considerably.


    While Inseego’s share price will continue to reflect the success of the company’s turnaround strategy, the fact that the stock has broken above a multi-year downtrend line can only be viewed as a bullish development. And assuming the stock continues to attract buyers on a dip to $3.20, there’s no reason an earnings-related breakout above $6 can’t propel the stock toward its decade-old highs near $12.

    The shares were recently trading 3.7% higher to $5.41 on Nasdaq.

    Verizon has gone on record as describing 5G as the Fourth Industrial Revolution, where everything that can be connected will be and the "full force of transformative technologies like artificial intelligence and autonomous vehicles will permeate where we live, work and play.”

    And if you’re an aggressive investor in search of a microcap company with an early leg up on the competition, there’s no question Inseego should be at the top of your 5G-related watchlist.

    At the time of publication, Byrne had no positions in the stocks mentioned.

    --Adds recent share price--

    Thu, 21 Feb 2019 07:00:00 -0500
    Namaste Technologies to broaden use of product markers Namaste Technologies (CVE:N) (OTCMKTS:NXTTF) will broaden the use of YPB Group Ltd (ASE:YPB) product markers, which are designed to protect consumers from the health, safety and quality risks associated with counterfeit products. 

    "We want to do the best by our consumers and brands by taking proactive measures to ensure the authenticity of the products we sell through our platform," said Meni Morim, CEO of Namaste Technologies in a news release. "We believe YPB has a strong solution and we expect that the connectivity and authenticity features will be welcomed as a value-add by our brand clients and consumers."

    Product authenticity and consumer engagement solutions provider YPB Group in a statement Wednesday that its markers also provide greater market intelligence through consumer data captured through YPB's Connect platform.

    READ: Namaste Technologies reaches settlement with ousted CEO Sean Dollinger, taps Branden Spikes as chairman

    According to a statement, YPB will receive A$0.13 per product that is marked with its label solution and said other methods of marking are currently being developed, which will result in serialization of product packaging. The company said if the packaging is marked with a printed code, the price per product would be between A$0.01 and A$0.05.

    "We are seeing a new level of consumer expectation that the products purchased are genuine, safe and socially responsible," said John Houston, CEO of YPB Group. "Brands are increasingly seeing the reputational and financial damage that results from counterfeit products. It is great to see that the e-commerce platforms are taking the initiative to herald this new age, and YPB believes that it is exceptionally well-placed with the world's leading product authenticity technologies."

    YPB solution has advantages 

    The move by Namaste follows another globally significant precedent set by e-commerce giant, Amazon, which mandated anti-counterfeit markings on all products sold through its platforms.

    According to YPB Group, its solution has "distinct advantages over that announced by Amazon in terms of price, access the brand will have to data and importantly YPB's solution can be read by any smartphone without the need for an APP."

    Shares of Namaste Technologies were up 1% at C$1.14 on Wednesday. 

    Wed, 20 Feb 2019 18:43:00 -0500
    Otis Gold notes passing of advisory board member Roger Morton Otis Gold Corp (CVE:OOO) (OTCMKTS:OGLDF) announced Wednesday that Dr. Roger Morton, an original member of Otis's advisory board, has passed away. 

    "We are deeply saddened by Roger's sudden passing," said Dr. Roger Norwich, a director of Otis. "The board and the company are indebted to Roger for his leadership, dedication and significant contributions to Otis during his tenure on the advisory board. His quick wit, geologic insights and steady friendship will be missed by his many friends, colleagues and former students. Our thoughts are with Roger's family at this very difficult time."

    READ: Otis Gold says 59% boost in indicated gold resource estimate at Idaho project among 2018 milestones

    Born in 1935, Morton was educated at the University of Nottingham, where he first graduated with a BSc in geology/Earth sciences and later earned a PhD in geology/Earth sciences.

    Morton had a distinguished career in the field of geology. He was research fellow at the University of Oslo, a lecturer in geology at the University of Nottingham, a visiting professor at both the University of Hamburg in Germany and the University of Nancy in France. 

    More recently, he was a was a professor emeritus in the field of economic geology at the University of Alberta. 

    In addition to his academic career, Morton co-founded and was a vice-president of Golden Star Resources Ltd, initiating the acquisition and development of the Omai gold project in Guyana, which subsequently produced approximately 3.8 million ounces of gold from two open pits.

    Contact Katie Lewis at

    Wed, 20 Feb 2019 18:18:00 -0500
    Klondike Gold Corp to raise up to C$2.75 million to boost exploration at Yukon projects Klondike Gold Corp (CVE:KG) (OTCMKTS:KDKGF) said Wednesday it is aiming to raise up to C$2.75 million by way of a non-brokered private placement to bolster the company's exploration and development of the company's Yukon projects. 

    Klondike is focused on exploring the Lone Star Gold target at the confluence of Bonanza and Eldorado creeks, within a 557 sq/km property located on the outskirts of Dawson City, Yukon within the Tr'ondek Hwech'in First Nation traditional territory. 

    The company said the placement will be a mix of flow-through funds and non-flow-through funds. 

    READ: Klondike Gold identifies extensive gold soil anomalies at Yukon property

    The flow-through placement will consist of the sale of flow-through shares at C$0.22 per unit, consisting of one common share and one share purchase warrant. A flow-through vehicle passes income to investors to avoid double taxation.

    The non-flow-through placement will consist of the sale of units at a price of C$0.20 per unit, consisting of one common share and one share purchase warrant.

    The company said each warrant will entitle the holder to purchase one common share at a price of C$0.35 per common share for a period of three years from closing and that finder's fees may be paid.

    Funds raised will go towards continued exploration and development of the company's Yukon projects and for general working capital

    All securities issued under the placement will be subject to a four-month hold period from the date of issue in compliance with applicable securities laws. The placement is subject to final acceptance of the TSX Venture Exchange.

    Shares of Klondike Gold were at C$0.19 on Wednesday. 

    Contact Katie Lewis at

    Wed, 20 Feb 2019 17:23:00 -0500
    Voltaic Minerals completes L2 Cobalt acquisition Voltaic Minerals Corp (CVE:VLT) (OTCMKTS:VTCCF) announced Wednesday it has closed its acquisition of L2 Cobalt Inc.

    The firm said it closed its definitive agreement with L2 Cobalt and has purchased all of the issued and outstanding shares of L2 Cobalt in exchange for 4.8 million shares. 

    L2 Cobalt owns and has the right to acquire under option a total of 378 highly prospective lode claims in Silver Bow County, Montana, totalling 7,560 acres.

    READ: Voltaic Minerals agrees to buy Argentina mineral claims for $500,000

    According to a statement from Voltaic Minerals, "management believes that with an exploration program, it may be possible to discover a cobalt-rich base metal mineral deposit on the property of L2 Cobalt."

    L2 Cobalt's major asset is the Soap Gulch property option agreement from February this year with 1132144 BC Ltd.

    That grants to L2 Cobalt the right to earn 100% interest in the Soap Gulch site.

    The option payments, payable by Voltaic to 1132144 BC Ltd. to earn the 100% interest in the mineral claims listed in the Soap Gulch Option include:

    The payment of $150,000 and issue 500,000 shares within seven days of TSX Venture Exchange approval of the transaction.

    The firm will also pay $50,000 and issue $250,000 in company shares on the one-year anniversary of the approval date.

    Additionally, the firm will pay $25,000 and issue $500,000 in company shares on the two-year anniversary of the approval date.


    Wed, 20 Feb 2019 16:43:00 -0500
    NexTech AR Solutions breaks ground with "Try it on" AR technology NexTech AR Solutions (CSE:NTAR-OTC:NEXCF) Chief Executive Officer Evan Gappelberg sat down with Steve Darling from Proactive Investors Vancouver to talk about the disruptive augmented reality company. Gappelberg talked about their verticals in the company including the "Try it on" platform that will change to way consumers shop.

    Gappelberg also told Proactive about revenue for January 2019 and he sees the company moving forward this year and next. 

    Wed, 20 Feb 2019 16:25:00 -0500
    Buds & Duds: Tilray gains ground after buying world's largest hemp food manufacturer Buds of the day include Tilray (NASDAQ:TLRY), Weekend Unlimited (CSE:POT), while the duds are Wayland Group (OTCQB:MRRCF) (CSE:WAYL), MariMed Inc (OTCQB:MRMD). 

    Wed, 20 Feb 2019 15:35:00 -0500
    Mandalay Resources closes C$43M offering Mandalay Resources Corp (TSE:MND) (OTCMKTS:MNDJF), the metals miner, said it had raised C$43 million gross from the sale of 359.4 million subscription receipts at $0.12 each.

    That included a partial exercise of the over-allotment option for underwriters to purchase up to a further 15% of receipts at the same price, said the Toronto -based miner.

    READ: Mandalay Resources announces pricing of offering

    Earlier this month, the group, which has operating mines in Sweden and Australia, announced the public offering of as well as a US$8 million convertible bridge loan from an affiliate of CE Mining -- an investment fund advised by Plinian Capital Ltd, which is controlled by Mandalay Chairman Brad Mills.

    The bridge loan has a term of one year, has an interest rate of 10% and will be convertible at CE Mining's option into Mandalay shares at a price per share equal to C$0.108 subject to adjustment.

    Mandalay said the net proceeds of the financing are intended to fund working capital requirements, including capital development work at the Costerfield mine in Australia,  and tailings upgrade and capital development requirements at Bjorndal in Sweden.

    Debt restructuring

    The funds will also be used for debt restructuring, including establishing a cash reserve relating to the US$24.1 million principal amount outstanding of senior exchangeable gold bonds, and future planned exploration activities at high potential areas including at Costerfield, the Youle lode and deeper hole targets, and the emerging Aurora Zone at Björkdal.

    In connection with the closing of the bridge loan, Mandalay has obtained a waiver from HSBC Bank Canada (HSBC) under the miner's revolving credit facility with the bank.

    HSBC has waived any current breaches of the facility as well as any failure by Mandalay to comply with the financial covenants set out as at 31 December 2018 and 31 March 2019.

    Contact Giles at

    Wed, 20 Feb 2019 15:03:00 -0500
    Security Devices International makes big splash at Daytona 500 with Byrna Security Devices International (CSE:SDZ-POTCQB:SDEV) President Bryan Ganz joined Steve Darling from Proactive Investors Vancouver on Skype to talk about the launch of the Byrna non-lethal personal security device at the Daytona 500 Nascar race.

    Ganz talked about the public reaction on the device and just who was buying. He also gave Proactive and update on production of the devices.

    Wed, 20 Feb 2019 15:01:00 -0500
    CannTrust Holdings approved to uplist to NYSE CannTrust Holdings Inc (OTCMKTS:CNTTF) (TSE:TRST) CEO Peter Aceto tells Proactive Investors the Canadian-based cannabis company has been approved to list on the New York Stock Exchange, under the ticker CTST.

    Aceto says the company decided to uplist now because the company is increasing its product breadth as well as its global expansion. It's important for the future success of the company and its investor base to be as global as its patient and customer base, he says.

    Wed, 20 Feb 2019 13:34:00 -0500
    Cosmos Holdings names agribusiness exec Vassos Efthymiadis to advisory board Cosmos Holdings Inc (OTCQB:COSM) has added executive Vassos Efthymiadis to its advisory board.

    Efthymiadis boasts considerable experience in the agribusiness sector and joins the board of the international pharmaceutical company, having served as Managing Director of K&N Efthymiadis SA and the vice-president of the Redestos Agrotechnology Group, two agribusiness companies in Greece.

    READ: Cosmos Holdings pays off all its convertible debt

    Efthymiadis is also president of the Hellenic Crop Protection Association and a board member of the Hellenic Association of Chemical Industries.

    Grigorios Siokas, CEO of Cosmos, is bullish on Efthymiadis’s appointment, citing his expertise in European exports. “His experience with exports to various countries of Southeastern Europe will provide valuable insight as we expand. We are excited to welcome him to the Cosmos team,” Siokas said in a statement.

    READ: Cosmos Holdings focuses on Europe as it expands its global wholesale pharmaceutical business

    Efthymiadis is keen to start at Cosmos. “Coming from a not so dissimilar business segment, I feel confident my experience can contribute to the vision Greg and his great team are shaping regarding the future of the company and the best way to ensure its long-term growth,” he said in a statement.

    Cosmos Holdings is a pharmaceutical wholesaler with offices and warehouses in Thessaloniki and Athens, Greece as well as the UK.

    Cosmos shares traded 1.7% higher to hit $3.50 on Wednesday morning.

    Contact Ellen Kelleher at

    Wed, 20 Feb 2019 12:01:00 -0500
    Nano One wants to be the power behind low-cost, high-performance battery materials
  • Currently has 11 patents issued around the world with more pending

  • Recently signed a joint agreement with Chinese cathode producer, Pulead Technology Industry

  • Signed a joint agreement with French multinational Saint-Gobain.

  • Financed into 2020; also received C$4.6 million in government grants

  • What Nano One Materials does

    Nano One Materials Corp (CVE:NNO) (OTCMKTS:NNOMF) is a Canadian technology company that designs the materials that go into lithium-ion batteries. Nano One has an industrial process for producing low-cost, high-performance battery materials and a wide range of other advanced nanostructured composites. 

    The company’s patented three-stage process uses equipment that is common in industry and is being engineered for high-volume production and rapid commercialization. Nano One’s method combines materials at the atomic level instead of the industry standard which involves mechanically melting, grinding and milling materials. 

    How is it doing?

    Nano One currently has 11 patents issued around the world, with more in the pipeline for 2019. There are currently more than 30 patents pending. 

    A number of recent deals are compelling. Nano One recently signed a deal with Chinese cathode producer Pulead Technology Industry with an aim to improve the cost and performance of lithium iron phosphate (LFP) cathode materials. Licensing and commercialization opportunities will also be explored as part of the collaboration.

    "Pulead is a highly respected cathode producer with a track record of partnering with international providers of intellectual property," said CEO Dan Blondal. "By working together, we aim to improve the cost and performance of LFP materials and to expand its use in industrial batteries, e-buses and electric vehicles."

    Nano One's scientific team has developed an innovative process that simplifies the production of high-performance carbon-coated LFP. The technology improves operating and capital expenses through the use of lower-cost raw material inputs with fewer process steps.

    Nano One also recently signed a deal with French materials giant Saint-Gobain. The two companies will work together to enhance high-temperature processing of Nano One’s lithium-ion battery materials.

    The company says Saint-Goban’s materials are complementary to Nano One’s processing technology and the agreement adds to its current efforts with other strategic interests in the lithium-ion battery supply chain.

    Last, but not least, the company has begun working with a tier-1 automotive supplier to develop cobalt-free high-voltage spinel (HVS) and nickel-rich NMC cathode materials to advance solid-state lithium ion batteries. There is a global effort to make solid-state batteries commercially viable, and Nano One’s technology is contributing to the development of the required cathode materials.

    Financially charged 

    From a financing perspective, Nano One is fully financed into 2020, after raising significant capital in 2016 and 2017. It has been the benefactor of a number of Canadian government grants, totalling C$4.6 million. 

    Market forecasts project that demand for the cathode materials in lithium-ion batteries will reach US$10 billion by 2025.

    What the boss says

    “These two relationships are the first two of many that we’ve got in the pipe” says CEO Dan Blondal about the Pulead and Saint-Goban joint agreements. “We’re talking to large automotive OEM’s around the world, we’re talking to chemical companies and battery companies and you can expect to hear more announcements throughout the year.”



    Contact Katie Lewis at

    Wed, 20 Feb 2019 11:32:00 -0500
    Fireweed Zinc closes 5 million dollar private placement which includes strategic investor Fireweed Zinc (CVE:FWZ) President and CEO Brandon MacDonald sat down with Steve Darling from Proactive Investors Vancouver to share news the company has just completed a cash raise of 5 million dollars to continue work on the Macmillan Pass Zinc project in the Yukon.

    MacDonald also telling Proactive the other key part to the influx of cash is where some of the money is coming from. Mining giant Teck Resources has increased their interest in the company to 9.9 percent.

    Wed, 20 Feb 2019 11:25:00 -0500
    Arca Biopharma rockets after FDA agreement for Phase 3 trial of Gencaro Arca Biopharma Inc (NASDAQ:ABIO) stock rocketed Wednesday after it reached an agreement with the US Food and Drug Administration (FDA) regarding the design of a pivotal Phase 3 clinical trial, PRECISION-AF, to assess the safety and potency of Gencaro (bucindolol hydrochloride) versus Toprol-XL (metoprolol succinate) for the treatment of atrial fibrillation (AF) in patients with a specific type of heart failure.

    Shares in the biotech soared 81.1% to $0.70.

    The trial is designed as a double-blind, active-controlled, multicenter, international study comparing Gencaro with Toprol-XL for the prevention of atrial fibrillation recurrence and will enroll approximately 400 subjects.

    READ: CytoDyn’s leronlimab reduces by more than 98% human breast cancer metastasis in mouse xenografts

    The Westminster, Colorado-based biotech said the primary endpoint “will be the time to first event of atrial fibrillation/atrial flutter or all-cause mortality during the 26-week follow-up period.”

    In the recently completed GENETIC-AF trial, Gencaro showed a 58% treatment benefit compared to Toprol-XL in reducing AF recurrence.

    If PRECISION-AF is successful and Gencaro gains regulatory approval, it will be the first genetically-targeted cardiovascular therapy.

    "This Special Protocol Assessment (SPA) agreement with the FDA provides a clearly defined regulatory pathway for the Phase 3 development of Gencaro in a genotype-specific heart failure population that currently has no FDA approved drug therapy," Arca Biopharma CEO Michael R Bristow said in a statement. “If the foundational therapeutic observations in the GENETIC-AF and BEST trials are confirmed in PRECISION-AF, Gencaro could potentially provide a new standard of treatment for AF prevention for 2.5 million HFmrEF patients in the US, Europe and Japan."

    The Gencaro development program enjoys FDA Fast Track designation.

    Contact Uttara Choudhury at

    Follow her on Twitter@UttaraProactive 

    Wed, 20 Feb 2019 10:45:00 -0500
    Tilray buys world's largest hemp food manufacturer Manitoba Harvest for C$419M Tilray Inc (NASDAQ:TLRY) is splashing out and paying C$419 million to buy Manitoba Harvest, which bills itself as the world’s largest hemp food manufacturer.

    The deal allows the cannabis company to forge ahead in the lucrative market for cannabidiol (CBD), which is derived from hemp plants, as well as sell hemp foods and supplements.

    “We’re excited to work with Manitoba Harvest to develop and distribute a diverse portfolio of branded hemp-derived CBD food and wellness products in the US and Canada,” said Brendan Kennedy, Tilray’s CEO, in a statement.

    READ: Tilray acquires Natura Naturals Holdings in deal worth up to C$70M

    Under the agreement’s terms, Tilray, which is based in Nanaimo, British Columbia, will acquire Manitoba, which is based in Winnipeg,  in a cash and stock deal worth up to C$419 million (US$317 million) pending the achievement of certain milestones after the closing of the transaction.

    Tilray will pay C$150 million in cash and C$127.5 million in shares upon the closing of the transaction. Six months later, Tilray will pay C$50 million in cash and C$42.5 million in stock. Tilray will also issue an additional C$49 million in stock if Manitoba Harvest achieves performance milestones in 2019.

    READ: Tilray and Anheuser-Busch InBev enter partnership to research cannabis drinks

    By leveraging Manitoba’s distribution network, Tilray plans to accelerate its expansion into the US and Canada, where legal, for CBD products. The passage of the US farm bill, which sanctions industrial hemp and CBD, represents a windfall for companies like Tilray that are eager to sell CBD products in the US.

    Products in the Manitoba Harvest portfolio include Hemp Hearts, Hemp Oil, Hemp Yeah! Granola, Hemp Yeah protein powder and Hemp Bliss milk. Manitoba has plans to launch a line of CBD containing hemp extracts as well as a line-up of Hemp Yeah! Wellness bars this summer.

    Tilray shares traded 6.6% higher at $82.11 in morning trade on Wednesday.

    Contact Ellen Kelleher at

    Wed, 20 Feb 2019 10:02:00 -0500
    Renaissance Gold inks earn-in deal with OceanaGold for Fat Lizard project, Nevada Renaissance Gold Inc (CVE:REN) (OTCQB:RNSGF) has struck an earn-in agreement with mid-tier miner OceanaGold for the former's Fat Lizard project in Nevada.

    OceanaGold has the option to earn up to a 51% interest in the project by spending US$3 million over five years and making payments to Renaissance of US$225,000.

    In addition, OceanaGold must spend US$250,000 within 12 months of signing the definitive agreement.

    Upon vesting, OceanaGold has a one-time option to earn a further 24% of Fat Lizard by spending a further US$5 million over four years from the date of exercise of the Phase II earn-in option.

    In January this year, the firm announced an earn-in deal with OceanaGold for its Spring Peak gold project, also in Nevada.

    "We are very pleased to have completed a second earn-in agreement with OceanaGold," said Robert Felder, president and CEO of Reno-based Renaissance. "They have a proven track record and are very active in Nevada and are a welcome addition to our list of partners. RenGold continues to maintain a very active exploration program throughout Nevada, and with the addition of this agreement, the company currently has eight active exploration agreements in Nevada funded by six different partners."

    Fat Lizard in Nye county consists of a gold and silver bearing volcanic-hosted, low-sulfidation epithermal system.

    Mineralization occurs along a 1.2 km long mineralized fault zone and is open to the west. The firm says potential Au-Ag-rich (gold-silver) mineralization may occur at relatively shallow depths within a boiling horizon. This prospect has never been drilled.

    Wed, 20 Feb 2019 09:55:00 -0500
    AUM Biosciences looks to advance anti-cancer molecule to Phase 2 later this year AUM Biosciences CEO Vishal Doshi sat down with Proactive Investors at the BIO CEO and Investor Conference in New York.

    AUM Biosciences is a Singapore-based oncology-focused biotech company.

    Wed, 20 Feb 2019 09:47:00 -0500
    Aurora Cannabis unveils board changes Aurora Cannabis Inc (NYSE:ACB) (TSE:ACB) announced Wednesday that it is shaking up its board with a series of changes.

    As part of the moves, Michael Singer, formerly chairman of the board, has been appointed executive chairman. Independent director Ronald Funk, meanwhile, has been tapped as a lead independent director. Margaret Atkins, a former Bain & Company executive who has experience in overseeing public company reporting, has been named a new independent director and chair of the audit committee.

    READ: Aurora Cannabis makes first shipment of medical cannabis to the UK

    In other news, Diane Jang, CEO of Hempco Food and Fiber, has stepped down as a director of Aurora after serving on the company’s board since November of 2017.

    “As Aurora continues to mature into one of the world’s largest and leading cannabis companies, it is important that our board continues to examine its composition to ensure that its experience and expertise aligns with the company’s strategic direction,” said Michael Singer, executive chairman, in a statement.

    Headquartered in Edmonton, Alberta, Aurora boasts cannabis operations in 23 countries.

    Contact Ellen Kelleher at

    Wed, 20 Feb 2019 09:26:00 -0500
    Zynerba Pharmaceuticals adds pharma exec to its board Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) said Wednesday that it has appointed Pamela Stephenson to its board of directors.

    Stephenson is currently vice president of Global Market Access and Value at Vertex Pharmaceuticals Inc (NASDAQ:VRTX), where she has served since 2008. Prior to that, she spent 10 years at Pfizer Inc (NYSE:PFE) in various capacities.

    “Zynerba is in an important phase of its journey as it begins its preparations for a potential launch of the first product ever indicated for use in children and adolescents with Fragile X Syndrome,” said Stephenson in a statement. “I am excited to join Zynerba’s board of directors at this time, and look forward to contributing to the company’s future successes.”

    The Devon, Pennsylvania, company develops transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, including Fragile X Syndrome – a genetic cause of intellectual disability -- and Autism Spectrum Disorder.

    “Pamela brings with her a wealth of expertise in commercial planning, market development, product launch and market access,” said Zynerba CEO Armando Anido. “This experience will be essential as we develop the market for ZYN002 in Fragile X Syndrome and await data from our ongoing pivotal CONNECT-FX study.”

    Zynerba shares closed at $5.03 Tuesday.

    Contact Paul Curcio at

    Follow him on Twitter @GoCurcioGo

    Wed, 20 Feb 2019 08:56:00 -0500
    iAnthus Capital launches second New York cannabis dispensary iAnthus Capital Holdings (CSE:IAN) (OTCQX:ITHUF) announced Wednesday that it has opened its second New York cannabis dispensary in the Dutchess County town of Wappingers Falls.

    The 2,600 square foot dispensary is called Citiva Hudson Valley and is located at 1147 Route 9, about 90 minutes north of New York City.

    On the list of offerings at the new dispensary are vape cartridges, tinctures, capsules and powders.

    READ: iAnthus Capital Holdings' revenue climbs in first half of 2018, but sees a net loss of US$36.2mln

    The opening of a Hudson Valley location follows iAnthus’s move to launch its first New York dispensary in Brooklyn in December 2019. Two additional locations in Staten Island and Chemung County are in the works.

    "The opening of our Citiva Hudson Valley dispensary is a major milestone for iAnthus, as it marks the 20th dispensary opened by the Company," said Hadley Ford, CEO of iAnthus. "2019 will be full of catalysts and exciting developments for Citiva, including the much-anticipated completion of our cultivation facility in Warwick, New York, and the opening of dispensaries in Staten Island and Chemung County."

    READ: Cannabis group iAnthus unveils $835m takeover of MPX Bioceutical

    IAnthus operates 20 dispensaries in 11 US states. Only registered patients with a New York medical cannabis card may purchase cannabis products.

    The cannabis company's shares finished 1.9% lower to hit C$7.15 on Tuesday.

    Contact Ellen Kelleher at

    Wed, 20 Feb 2019 08:52:00 -0500
    Haydale confirms funding talks with institutions Haydale Graphene Industries PLC (LON:HAYD) has confirmed it is talking to institutions about a funding round at well below last night’s closing price.

    The funding would also include an open offer to existing shareholders said the composite materials specialist.

    Haydale raised £1mln in December through a through a £750,000 loan from the Development Bank of Wales and a £250,000 share subscription.

    Wed, 20 Feb 2019 08:33:00 -0500
    Duos Technologies deploys new dcVue security software for the first time Duos Technologies Inc (OTCQB:DUOT) said Wednesday that it has successfully deployed its new dcVue software as a commercial application for the first time.

    The system, which works with Android phones and other mobile devices, is used to verify assets within data centers. Once an accurate picture of a company’s data center assets and their location is compiled, the system can be used for auditing, monitoring and recording the movement of assets as well as additions, changes and deletions from that inventory.

    The sale of the system, which was tested first, was arranged by Duos’s partner, FNT Software.

    READ: Duos Technologies launches artificial intelligence subsidiary truevue360

    “We believe this initial sale through our partner, FNT, validates the need for accurate asset information within any data center,” said Geoffrey Greene, director of business development for Duos’s Information Technology Asset Management division.

    In dcVue’s data collection mode, users can gather information about physical assets throughout the entire data center. The software can be used in conjunction with FNT’s management solution program, FNT Command.

    READ: Duos Technologies wins another key contract from Canadian National Railway

    Based in Jacksonville, Florida, Duos is a tech company that offers an array of services to support companies' operations and security. It specializes in rail train inspections that rely on Duos’ proprietary rip technology and use an automated process which can be conducted while a train is in motion. Duos’s technology takes detailed, real-time, full-picture images of rail cars traveling at great speeds.

    Duos shares closed up 2% to hit $0.55 on Tuesday.

    Contact Ellen Kelleher at


    Wed, 20 Feb 2019 08:25:00 -0500
    CytoDyn’s leronlimab reduces by more than 98% human breast cancer metastasis in mouse xenografts CytoDyn Inc (OTCMKTS:CYDY), a Vancouver-based biotech announced Wednesday that it was able to reduce by more than 98%, the incidence of human breast cancer metastasis in a mouse xenograft (tissue graft) model for cancer through six weeks with its flagship leronlimab (PRO 140) antibody.

    As part of CytoDyn's recent acquisition of ProstaGene, CytoDyn received control of a prestigious lab in Philadelphia led by the company’s chief medical officer Dr Richard G Pestell. The company announced on Tuesday that the Philadelphia lab will conduct eight pre-clinical studies on melanoma, pancreatic, breast, prostate, colon, lung, liver and stomach cancer. CytoDyn pegged the cost of running the preclinical studies for the eight cancers and submission of Phase 2 IND applications at roughly $1.5 million.

    READ: CytoDyn to initiate 8 preclinical animal studies with leronlimab for multiple cancers

    Leronlimab (PRO 140) is a humanized IgG4 monoclonal antibody that blocks CCR5, a cellular receptor that plays multiple roles with implications in HIV infection, tumor metastasis, and immune signaling.

    Based on the results, CytoDyn announced its plans for the expansion of pre-clinical animal studies into eight cancer indications, driven in part on prior research by Dr Pestell, suggesting that CCR5 inhibition may disrupt signaling and ultimately the spread of CCR5+ circulating tumor cells.

    In Dr Pestell’s research laboratory, pre-clinical studies were conducted on mice using Pfizer’s HIV drug maraviroc in breast and prostate cancer.  Results were most encouraging using these CCR5 inhibitors, which ultimately led Dr Pestell to design experiments applying leronlimab (PRO 140) to metastatic mouse models. The results of this pre-clinical study using leronlimab (PRO 140) in mice showed a reduction in breast cancer metastasis of more than 98% over the six-week period of the study.

    The mouse xenograft model is designed to mimic human breast cancer metastasis. The biotech said it is optimistic after finding more than 98% reduction in tumor metastasis over a six-week period in the mouse model. The “temporal equivalency” of the six weeks study, may be up to six years in humans, pointed out the company.

    “These positive pre-clinical results are very promising, and it gives new hope for future treatment options to cancer victims all over the world,” said CytoDyn CEO Dr Nader Pourhassan in a statement. “We are working diligently to present an abstract of this data in conference as soon as possible.”

    The CEO said their findings could result in “new treatment options of this kind” for late-stage cancer patients, who often experience deadly metastasis.

    “Should CytoDyn’s mouse xenograft breast cancer metastasis studies using leronlimab (PRO 140) correlate in humans as Pfizer’s drug maraviroc did in colon cancer, in a trial conducted in Germany, this could open new possibilities for treatment options for breast cancer,” said Dr Pourhassan.

    He said the company was looking forward to interim data from its human trial in triple-negative breast cancer, which is expected to be available within the next few months.

    “If interim results are positive, we will promptly file for breakthrough therapy designation,” said Dr Pourhassan. “Negotiation of potential licensing opportunities has started on several fronts. We hope to reach a definitive deal regarding a commercialization partnership for HIV and/or GvHD, which would further enhance the trajectory of our company.”

    Contact Uttara Choudhury at

    Follow her on Twitter@UttaraProactive 


    Wed, 20 Feb 2019 07:51:00 -0500
    Weekend Unlimited acquires R&D Pharma's Jamaican assets Weekend Unlimited Inc (CSE:POT) (OTCMKTS:WKULF) announced Wednesday that it has completed its arms-length acquisition of R&D Pharma’s Jamaican interests.

    To complete the deal, the cannabis-focused investment company issued 80 million shares at a price of $0.25 and also made 25 million warrants available to the shareholders of R&D Pharma. Each warrant entitles the holder to acquire an additional share for $0.35 for a period of two years.

    READ: Weekend Unlimited signs definitive agreement with R&D Pharma for Jamaican interests

    About 49 million shares are subject to a voluntary escrow agreement that sees 20% released at closing and the balance given in six equal instalments over three years.

    Called Tropicann Jamaica, the R&D Pharma property now spans 98 acres, 60 acres of which are usable for cultivation. The Jamaican company is now producing 13 acclimated strains of cannabis and 120 mother plants.

    “With our Tier-3 cultivators license, our active focus is on medical tourism in Jamaica, having designed and constructed the first of our ‘Ganja Café’s’ within a short tour bus ride from the cruise ship terminals in Ocho Rios,” said Richard Bailey, president of R&D Pharma, in a statement.

    READ: Weekend Unlimited closes "highly strategic" Canna Candys, Medibles acquisition

    Currently, there are 5.2 acres of terraced outdoor cultivation being used at the site. This includes 3.2 acres of commercial cultivation, which is capable of producing 5,750kg of dry material per year. The remaining two acres are used for research and development, producing 3,000kg.

    The site also boasts a 6,000 square foot greenhouse, which houses a 3,600 square foot flower room; this facility is able to produce 600kg of dry material per year for an onsite dispensary, which is planned to serve tourists.

    Based in Vancouver, Weekend Unlimited is a cannabis-focused investment company that specializes in the scaling of small to medium brands, primarily in the categories of flower, extracts and edibles.

    Weekend Unlimited shares added 6.9% to finish trading at C$0.16 on Tuesday.

    Contact Ellen Kelleher at

    Wed, 20 Feb 2019 07:47:00 -0500
    Sainsbury's plunges as UK regulators leaning towards blocking £10bn Asda merger J Sainsbury plc (LON:SBRY) saw its shares plunge on Wednesday after UK regulators hinted they are swaying towards blocking the supermarket giant's proposed £10bn merger with Wal-Mart Inc (NYSE:WMT) owned Asda after an in-depth investigation found “extensive competition concerns”.

    Provisional findings from the Competition and Markets Authority’s (CMA) probe suggested that the tie-up between the UK’s second and third largest food retailers could lead to a “worse experience” for shoppers both in-store and online.

    READ: Sainsbury’s could absorb at least 132 store closures, says UBS

    Top of their fears was that food and petrol prices could rise, while the quality and number of product ranges offered could reduce. Overall, the CMA found that any deal could lead to a “sUBStantial lessening of competition”, especially in areas where Sainsbury’s and Asda stores overlap.

    In reaction, Sainsbury's shares  tumbled 13.2% lower to 249.80p, while rival food retailers also fell with Wm Morrison Supermarkets PLC (LON:MRW) - seen as a possible beneficiary from merger store sell-offs - shedding 4.6% at 229p, and market leader Tesco PLC (LON:TSCO) down 0.3% at 227p.

    Laith Khalaf, senior analyst at Hargreaves Lansdown commented: “The supermarkets will now have to bend over backwards if they want to proceed with the merger, and even then, wouldn’t be guaranteed a favourable ruling from the CMA.

    “The thorny issue of competition in the online delivery market also means they may have to get rid of one of the brands, reducing their ability to target different customer bases.

    They also have to find a suitable buyer for the assets on sale, one who is big enough to provide proper competition in the eyes of the regulator.”

    In a statement reacting to the CMA news, Sainsbury’s said it “fundamentally disagree[d]” with the findings and would continue to make its case in the coming weeks.

    “These [findings] misunderstand how people shop in the UK today and the intensity of competition in the grocery market,” read their response.

    “Combining Sainsbury's and Asda would create significant cost savings which would allow us to lower prices. Despite the savings being independently reviewed by two separate industry specialists, the CMA has chosen to discount them as benefits.”

    Three options now

    The CMA said there were now three options on the table:

    1. it could block the merger entirely
    2. it could force Sainsbury’s and Asda to sell off a “significant number of stores”
    3. or, it could make the pair sell off other assets – including one of the Sainsbury’s or Asda brands

    UBS analysts have previously said that the deal would still be worthwhile for Sainsbury’s and Asda even if they were forced to close as many as 132 stores.

    But the CMA hinted that it is more in favour of option one – blocking the deal altogether – after claiming that it is “likely to be difficult for the companies to address the concerns it has identified”.

    Stuart McIntosh, chair of the independent inquiry group carrying out the investigation, said: “These are two of the biggest supermarkets in the UK, with millions of people purchasing their products and services every day.

    Final decision due by end of April

    “We have provisionally found that, should the two merge, shoppers could face higher prices, reduced quality and choice, and a poorer overall shopping experience across the UK. We also have concerns that prices could rise at a large number of their petrol stations.

    He added: “These are our provisional findings, however, and the companies and others now have the opportunity to respond to the analysis we've set out today. It's our responsibility to carry out a thorough assessment of the deal to make sure that the sector remains competitive and shoppers don't lose out.”

    The two grocers have until 6 March to suggest possible remedies that could convince the CMA to approve the merger.

    Interested parties, which may include retail rivals Tesco PLC (LON:TSCO) and Wm Morrison Supermarkets PLC (LON:MRW), have until 13 March to respond to the provisional findings.

    The final report is due to be issued before the end of April.

     -- Adds share prices, analyst comment --

    Wed, 20 Feb 2019 07:45:00 -0500
    Quizam Media expanding e-learning to new markets, opens new cannabis division Quizam Media and Quantum 1Cannabis  (CSE:QQ) CEO Russ Rossi sat down with Steve Darling with Proactive Investors Vancouver to discuss his online learning course company. Rossi talked about how the products work and some of the new markets they are now operating in.

    Rossi also told Proactive about their subsidiary Quantum 1 Cannabis Corporation and what type of stores they hope to open.

    Wed, 20 Feb 2019 07:31:00 -0500
    Iplayco’s latest quarter numbers scores higher sales and better profit margins Iplayco (CVE:IPC) Chief Financial Officer Max Liszkowski joined Steve Darling from Proactive Investors Vancouver on Skype with news of their latest quarterly earnings that show the company enjoyed higher sales and the margins were much better as well.

    Liszkowski also telling Proactive talked about the long-term strategy for Iplayco and what he sees as the key activity number over the next six months.

    Wed, 20 Feb 2019 06:48:00 -0500
    Universal mCloud bolsters team with chief product officer appointment Universal mCloud Corp (CVE:MCLD) (OTCQB:MCLDF) announced Tuesday that it continues to strengthen its team, with the promotion of Dr. Barry Po to the position of chief product officer. 

    Po will lead mCloud's product management and marketing activities.

    The Vancouver-based specialist in artificial intelligence and analytics and internet of things said the move will help the company advance and accelerate its AI and analytics agenda.

    WATCH: Universal mCloud teams up with Chinese partner to deliver smart-building technology

    "Since our acquisition of NGRAIN, Barry has expertly executed and shaped mCloud's product and marketing strategies,"  said president and CEO Russ McMeekin in a statement. "In his new role, Barry will lead our product teams and work to build mCloud's presence in key markets. Our leadership team looks forward to working closely with this impressive individual and benefitting from his strong leadership and expertise."

    Po joined mCloud in 2018 through mCloud's acquisition of NGRAIN (Canada) Corporation. As part of the senior leadership at NGRAIN, he oversaw product management, marketing, and business development. He has 15 years of product leadership experience and has taken numerous high-tech offerings to market, delivering products and services to millions of customers in over 80 countries around the world.

    "mCloud's application of AI and analytics is solving some of the world's most challenging energy problems," said Po. "I am excited to help lead this innovative company and enable more customers to maximize the health and performance of their energy assets."

    Universal mCloud specializes in using advances in artificial intelligence and analytics to address energy infrastructures such as HVAC (heating, ventilation and air conditioning) units in commercial buildings, wind turbines and distribution transformers.

    Shares of Universal mCloud were at C$0.33 on Tuesday. 

    Contact Katie Lewis at

    Tue, 19 Feb 2019 17:21:00 -0500
    ShotSpotter swings to first quarterly profit thanks to sales of gunshot detection tool ShotSpotter (NASDAQ:SSTI), the gunshot detection specialist, late on Tuesday reported it swung to a profit (GAAP basis) in the fourth quarter for the first time thanks to sales of its flagship gunshot detection tool.

    For the three months ending December 31, net income came to $302,000, or $0.03 per share, rebounding from a loss of $2.5 million in the year-ago quarter. Revenue, meanwhile, came in at $9.7 million.

    The results surpassed the estimates of analysts who had expected the Newark, California-based company to break even on revenue of $9.47 million.

    ShotSpotter shares were up 1.1% to $48.72 in Wednesday morning trading.

    READ: ShotSpotter beats Street's 3Q revenue estimate, but falls short on earnings forecast

    “There’s no question that ShotSpotter had a strong Q4,” said Bob Byrne, a contributor to Proactive Investors and trader. “The company beat (incrementally) on both the top and bottom line.”

    The company has developed the technology to pinpoint when and where a gun has been fired. The company’s flagship product ShotSpotter Flex is a gunshot detection, location and forensic analysis system. Through the use of multiple sensors and acoustic experts, the tech can detect the time, location, direction and angle of the explosion caused by a gun and send crucial information to 911 dispatchers and other first responders.

    Its second program, which launched just last year, is ShotSpotter Missions, which uses artificial intelligence-driven analysis to plan patrol missions at police departments.

    Outlook in focus

    Looking ahead to 2019, ShotSpotter reaffirmed its revenue outlook to a range of $45 million to $47 million, which represents an increase of 29% to 35% compared to 2018.

    While the company expects a GAAP net loss in the first quarter of 2019, it expects to achieve GAAP profitability for 2019.

    Byrne predicts that ShotSpotter’s stock will dip and consolidate around $38 to $40 before attempting to move higher.

    “ShotSpotter put up a fine quarter and continues to grow at an impressive rate,” Byrne said. “But given the stock’s rich valuation, I believe the stock needs to consolidate its recent gains.”

    --Updates share price--

    Contact Ellen Kelleher at 

    Tue, 19 Feb 2019 16:32:00 -0500
    CytoDyn to begin preclinical studies with leronlimab for 8 different cancers CytoDyn Inc (OTCQB:CYDY) CEO Dr. Nader Pourhassan and Chief Medical Officer Dr. Richard Pestell tell Proactive Investors its new lab in Philadelphia led by Dr. Pestell will conduct eight pre-clinical studies on melanoma, pancreatic cancer, breast cancer, prostate cancer, colon cancer, lung cancer, liver cancer, and stomach cancer.

    Dr. Pestell says these indications were chosen, as they tend to spread fast, and are particularly deadly cancers.

    Tue, 19 Feb 2019 16:26:00 -0500
    BioCorRx seeks FDA approval on its anti-opioid and alcoholism naltrexone implant BioCorRx Inc (OTCQB: BICX) CEO Brady Granier tells Proactive Investors the California-based developer of substance use disorders treatments has been awarded a $5.7 million, two-year grant from the National Institutes of Health for the development of BICX102, the company’s sustained release naltrexone implant for the treatment of opioid use addiction and alcoholism.

    Granier says once the implant is approved, he envisions the company attaching its cognitive behavioral therapy and peer support program to provide more tools for physicians prescribing the product.

    Tue, 19 Feb 2019 16:17:00 -0500
    FSD Pharma CEO updates corporate moves, progress at hydroponic cannabis facility FSD Pharma Inc (CSE:HUGE) (OTCQB: FSDDF) interim CEO Dr. Raza Bokhari updates Proactive Investors on the cannabis company's partners, management, and recent achievements.

    Bokhari says FSD is on track to transform its 25,000 sq. ft facility in Cobourg, Canada into the world’s largest hydroponic indoor cannabis production and processing facility.

    Tue, 19 Feb 2019 15:59:00 -0500
    International ZeoLite Corp receives positive poultry barn results. International Zeolite (CVE:IZ-OTCQB:IZCFF) CEO Ray Paquette sat down with Steve Darling from Proactive Investors Vancouver to talk about their company which makes products from Zeolite, one of the most versatile minerals on the planet.

    Paquette telling proactive some of the many uses for Zeolite and some of the markets the mineral is already being used and where there is great potential to grow sales.


    Tue, 19 Feb 2019 15:32:00 -0500
    American Manganese successfully completes stage 1 and 2 of battery recycling plant operation American Manganese  (CVE:AMY:OTC:AMYZF) President and CEO Larry Reaugh sat down with Proactive Investors Vancouver’s Steve Darling to share results from stages 1 and 2 of the Company’s lithium-ion battery recycling pilot plant operations. Stages 1 and 2 include the pre-treatment of feedstock material and a leach of the cathode active material.

    Reaugh telling Proactive that he is happy the company was able to see the patent-approved process demonstrated on a pilot scale. He also added, the successful replication of the lab-scale operations in a larger continuous closed-circuit operation, 
    not only is the first step towards commercialization, but also provides key evidence that the company’s lithium-ion battery recycling technology is economically sound


    Tue, 19 Feb 2019 15:03:00 -0500
    Buds & Duds: Namaste shares jump on settlement with former CEO Sean Dollinger Buds: Namaste Technologies (CVE:N) (OTCMKTS:NXTTF), 1933 Industries (CSE:TGIF) (OTCQX:TGIFF). 

    Duds: OrganiGram Holdings Inc (CVE:OGI), Canopy Growth (NYSE:CGC). 

    Tue, 19 Feb 2019 14:51:00 -0500
    NetCents develops technology to speed up transactions using cryptocurrency NetCents Technology (CSE:NC) Chief Technology Officer Mehdi Mehrtash sat down with Steve Darling from Proactive Investors Vancouver to discuss the release of its Zero Confirmation and Risk Analysis technology that guarantees cryptocurrency transactions before they are confirmed on the blockchain.

    Mehrtash talked about why they developed the technology and how they plan to use it for their current customers and others that can benefit from it.

    Tue, 19 Feb 2019 14:49:00 -0500
    Walmart-owned Asda sees Q4 sales growth slow as Sainsbury's merger decision looms Asda, the UK supermarket arm of Walmart Inc (NYSE:WMT) saw its sales growth slow in the fourth quarter of 2018 although it still reported a seventh consecutive quarter of positive year-on-year comparable sales growth as it waits on approval of its planned merger with J Sainsbury PLC (LON:SBRY).
    The food retailer reported a 1.0% increase in like-for-like sales excluding petrol in the fourth quarter of 2018, below the 2% increase reported in its third quarter,

    READ: CMA pushes back deadline for probe into Sainsbury’s-Asda merger

    Commenting on the performance, Asda's president and CEO, Roger Burnley, said: “2018 was another challenging year for the retail market and the pace of change shows no sign of abating." 
    He added: “The year ahead looks no less turbulent than the last, with uncertainties around Brexit playing on our customers’ minds.”
    In April 2018, Asda agreed to a £7.3bn cash and shares takeover by Sainsbury’s, a deal - which if approved - would see the new combined entity overtake Tesco PLC (LON:TSCO) as the UK's biggest supermarket group.

    The Competition and Markets Authority is currently probing the deal and is due to publish its preliminary findings later this month.

    In afternoon trading on Tuesday, shares in FTSE 100-listed Sainsbury's were up 0.6% to 287.6p. In early New York trading, Wal-Mart shares were up 3.5% at $103.52.
    Tue, 19 Feb 2019 14:35:00 -0500
    Primary Energy Metals reverse share split to roll out Tuesday Primary Energy Metals Inc (CSE:PRIM) (OTCMKTS:PEMTF) announced Tuesday it will consolidate its shares on a 1:10 basis, effective at the close of business on Tuesday.

    The Vancouver-based junior explorer will reduce the total number of shares in issue, while simultaneously increasing the nominal or par value of each of the shares.

    Its shares outstanding will reduce to around 8.16 million from around 81.6 million.

    READ: Primary Energy Metals to uplist to OTC Venture Market

    The company said there will be no change to the company's ticker symbol.

    Primary Energy Metals is focused on vanadium, cobalt, copper and nickel-focused mineral resource properties.

    Contact Katie Lewis:

    Follow her on Twitter: @kelewis

    Tue, 19 Feb 2019 13:52:00 -0500